These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 15851522

  • 1. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
    Looney RJ.
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
    [Abstract] [Full Text] [Related]

  • 2. Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.
    Kazkaz H, Isenberg D.
    Curr Opin Pharmacol; 2004 Aug; 4(4):398-402. PubMed ID: 15251135
    [Abstract] [Full Text] [Related]

  • 3. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S, Akashi T, Katsuta H, Iwakiri R, Anzai K, Nagafuchi S, Niho Y, Harada M.
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [Abstract] [Full Text] [Related]

  • 4. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F, Isenberg DA.
    Handb Exp Pharmacol; 2008 Apr; (181):163-81. PubMed ID: 18071946
    [Abstract] [Full Text] [Related]

  • 5. A review of the current use of rituximab in autoimmune diseases.
    Gürcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR.
    Int Immunopharmacol; 2009 Jan; 9(1):10-25. PubMed ID: 19000786
    [Abstract] [Full Text] [Related]

  • 6. What is the role of rituximab in the treatment of rheumatoid arthritis?
    Atzeni F, Doria A, Turiel M, Sarzi-Puttini P.
    Autoimmun Rev; 2007 Sep; 6(8):553-8. PubMed ID: 17854748
    [Abstract] [Full Text] [Related]

  • 7. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, de Vita S, Regazzi M, Baccarani M, Fanin R.
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R, Albert D.
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [Abstract] [Full Text] [Related]

  • 11. [CD20 antibody for the treatment of systemic autoimmune diseases].
    Tanaka Y.
    Nihon Rinsho; 2005 May; 63 Suppl 5():728-33. PubMed ID: 15954437
    [No Abstract] [Full Text] [Related]

  • 12. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.
    Silverman GJ, Weisman S.
    Arthritis Rheum; 2003 Jun; 48(6):1484-92. PubMed ID: 12794814
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. B cells in rheumatoid arthritis: from hypothesis to the clinic.
    Keystone EC.
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii8-ii12. PubMed ID: 15851525
    [Abstract] [Full Text] [Related]

  • 16. B cells move to centre stage: novel opportunities for autoimmune disease treatment.
    Browning JL.
    Nat Rev Drug Discov; 2006 Jul; 5(7):564-76. PubMed ID: 16816838
    [Abstract] [Full Text] [Related]

  • 17. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP.
    J Neuroimmunol; 2008 Nov 15; 204(1-2):1-12. PubMed ID: 18783837
    [Abstract] [Full Text] [Related]

  • 18. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T.
    J Rheumatol Suppl; 2006 May 15; 77():3-11. PubMed ID: 16652439
    [Abstract] [Full Text] [Related]

  • 19. CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.
    Perosa F, Prete M, Racanelli V, Dammacco F.
    J Intern Med; 2010 Mar 15; 267(3):260-77. PubMed ID: 20201920
    [Abstract] [Full Text] [Related]

  • 20. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
    Levesque MC, St Clair EW.
    J Allergy Clin Immunol; 2008 Jan 15; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.